SCHEMBL9054663

SCHEMBL9054663

CCP(O)(=S)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10430566 0.96 ALPG (0.33)
SCHEMBL13305909 0.84
Isothiocyanate SCHEMBL10489278 0.84
SCHEMBL13305915 0.79
SCHEMBL25682084 0.79
SCHEMBL432883 0.78
SCHEMBL13305889 0.75
Hydrochloric Acid SCHEMBL10750098 0.75
Propane SCHEMBL1972641 0.73 ALPG (0.39)
Propane SCHEMBL1974013 0.73 ALPG (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119306760-A Maleimide type flame retardant and preparation method thereof 深圳飞扬骏研新材料股份有限公司 2025-01-14 CN claimed
CN-119306760-A Maleimide type flame retardant and preparation method thereof 深圳飞扬骏研新材料股份有限公司 2025-01-14 CN disclosed
US-20230192844-A1 HUMANIZED ANTI-CD3 ANTIBODIES, CONJUGATES AND USES THEREOF THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH 2023-06-22 US disclosed
US-20170157104-A1 Anti-Viral Compounds ABBVIE INC. (US) 2017-06-08 US disclosed
US-20170002076-A1 TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF THE SCRIPPS RESEARCH INSTITUTE 2017-01-05 US disclosed
US-20160115232-A1 TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF THE SCRIPPS RESEARCH INSTITUTE 2016-04-28 US disclosed
US-9302274-B2 Collector compositions and methods of using the same CYTEC TECHNOLOGY CORP. (US) 2016-04-05 US disclosed
US-20150238631-A1 CHIMERIC ANTIGEN RECEPTOR T CELL SWITCHES AND USES THEREOF THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2015-08-27 US disclosed
WO-2015057852-A1 CHIMERIC ANTIGEN RECEPTOR T CELL SWITCHES AND USES THEREOF THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2015-04-23 WO disclosed
EP-2768616-A2 COLLECTOR COMPOSITIONS AND METHODS OF USING THE SAME Cytec Technology Corp. (US) 2014-08-27 EP disclosed
WO-2013059258-A2 COLLECTOR COMPOSITIONS AND METHODS OF USING THE SAME CYTEC TECHNOLOGY CORP. (US) 2013-04-25 WO disclosed
US-20130092603-A1 Collector Compositions and Methods of Using the Same CYTEC TECHNOLOGY CORP. (US) 2013-04-18 US disclosed
US-20100137258-A1 THIOPHOSPHI(O)NIC ACID DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2010-06-03 US disclosed
WO-1996001262-A1 NOVEL QUINOLINE COMPOUND AND PROCESS FOR PREPARATION THEREOF HANMI PHARMACEUTICAL CO., LTD. (KR) 1996-01-18 WO disclosed
EP-0571400-A1 NOVEL QUINOLONE COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF HANMI PHARMACEUTICAL CO.,LTD. (KR) 1993-12-01 EP disclosed
WO-1992012155-A1 NOVEL QUINOLONE COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF HANMI PHARMACEUTICAL CO., LTD. (KR) 1992-07-23 WO disclosed
US-4661278-A Monothiophosphinates as acid, neutral, or mildly alkaline circuit sulfide collectors and process for using same AMERICAN CYANAMID COMPANY (US) 1987-04-28 US disclosed
US-4587013-A Monothiophosphinates as acid, neutral, or mildly alkaline circuit sulfide collectors and process for using same AMERICAN CYANAMID COMPANY (US) 1986-05-06 US disclosed
US-4555368-A OXIDATION OF A PHOSPHINE, REACTION WITH SULFUR AND A HYDROXIDE AMERICAN CYANAMID COMPANY (US) 1985-11-26 US disclosed